Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Premium

Register

Sign In

EUR/USD

1.2288

-0.0056

-0.45%

GBP/USD

1.4003

-0.0079

-0.56%

USD/JPY

107.65

0.2200

0.20%

USD/CHF

0.9750

0.0033

0.34%

EUR/GBP

0.8774

0.0009

0.10%

USD/CAD

1.2765

0.0100

0.79%

NZD/USD

0.7208

-0.0057

-0.78%

EUR/JPY

132.29

-0.3180

-0.24%

EUR/CHF

1.1980

-0.0014

-0.12%

Celgene Corp. Contingent Value Rt

NASDAQ: CELGZHealthcare / Biotechnology / USA
0.25+0.04+19.05%Vol 10 6841Y Perf -77.27%
Apr 20th, 2018 13:43
BID0.24 ASK0.25
Open0.24 Previous Close0.21
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★★★     75.26
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)- 
Earnings Rating
Price Range Ratio 52wk %
9.33 
Earnings Date

Today's Price Range

0.240.25

 

52wk Range

0.111.61

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
-30.56%
3 Months
-72.53%
6 Months
-83.44%
1 Year
-77.27%
3 Years
-91.17%
5 Years
-73.82%
Last Quotes
Name / TickerPriceChg.Chg.%
CELGZ0.250.040019.05
AAPL165.72-7.0800-4.10
GOOG1 072.96-14.7400-1.36
MSFT95.00-1.1100-1.15
XOM79.00-0.4200-0.53
WFC52.561.02001.98
JNJ126.66-0.8900-0.70
FB166.28-1.8200-1.08
GE14.540.55003.93
JPM111.47-0.2500-0.22
...

TickerPriceChg.%52 Week High
RF18.894.0820.21
XRX31.543.9937.42
GE14.543.9330.38
HRB27.102.9231.80
ETFC60.482.8061.80
SCHW54.992.4458.11
SIG38.652.1777.94
UAL71.752.1683.04
WFC52.561.9866.31
RE246.991.91277.17
M29.961.8731.04
CTL17.611.6727.61
HON150.571.65165.13
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.70
Current Ratio 5.00
Long Term Debt to Total Capital 0.70
Total Debt to Equity 2.29
Interest Coverage 9.30
Leverage Ratio 3.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin96.50
EBIT Margin37.20
EBITDA Margin40.80
Pre-tax Profit Margin26.30
Profit Margin19.94
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio -
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -
Cash Flow Per Share -
Price to Tangible Book-
Book Value per Share-
Enterprise Value (in ths.)-
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)32.19
ROE last 12 Months 43.49
Return on Assets (5Y Avg) 6.84
ROA last 12 Months 10.10
Return on Capital (5Y Avg) 14.26
ROC last 12 Months 9.72
Return on invested Capital Q -0.03
Return on invested Capital Y14.95
Assets Turnover0.10
Receivables Turnover2.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)10 023 000
Revenue per Share -
Revenue Growth 3 Years 18.32
Revenue Growth 5 Years 18.89
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume10 684
Shares Outstanding (in ths.)0
Trades Count3
Dollar Volume2 331
Avg. Volume26 977
Avg. Weekly Volume6 957
Avg. Monthly Volume43 964
Avg. Quarterly Volume29 966

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

83%17%

Bearish Bullish

58%42%

Bearish Bullish

75%25%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News

x